Literature DB >> 33863607

Fertility preservation in women with peritoneal surface malignancies: A case series.

Francesca Filippi1, Shigeki Kusamura2, Fabio Martinelli2, Edgardo Somigliana3, Marcello Deraco2.   

Abstract

The advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has improved survival in patients with peritoneal surface malignancies. Not surprisingly, there is now a growing interest on the possible means to preserve fertility to ensure future childbearing. In this study, we report on five women with peritoneal surface malignancies who performed ovarian hyper-stimulation and oocytes cryostorage prior to undergo CRS and HIPEC. The presence of the disease complicated follicular growth monitoring but the oocytes retrievals could be always performed and were uneventful. At last follow-up, all women were alive and disease-free. None has yet returned to thaw her oocytes. Overall, these cases suggest that oocytes cryopreservation before CRS and HIPEC should be considered.
Copyright © 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Cytoreductive surgery; Fertility preservation; Hyperthermic intraperitoneal chemotherapy; Infertility; Oocyte; Primary peritoneal disease

Mesh:

Year:  2021        PMID: 33863607     DOI: 10.1016/j.ejso.2021.03.259

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  Benign Multicystic Peritoneal Mesothelioma Complicating Fertility Preservation.

Authors:  Satoshi Shikanai; Tasuku Mariya; Masahiro Iwasaki; Tsuyoshi Saito
Journal:  Gynecol Minim Invasive Ther       Date:  2022-05-04

2.  Prognosis for Young Females with Pseudomyxoma Peritonei of Appendiceal Origin and Unilateral or Bilateral Ovaries Preserved During Cytoreductive Surgery.

Authors:  Fengxian Fu; Huangdong Tang; Yiyan Lu; Dongmei Lu; Ruiqing Ma
Journal:  Front Surg       Date:  2022-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.